LARGO, Fla., Jan. 13 /PRNewswire-FirstCall/ -- GeoPharma, Inc. today announced that it will report results for the third quarter of fiscal 2006, ended December 31, 2005, on February 1, before market open.
GeoPharma will host a conference call to discuss results on February 1, 2006 at 11:00 a.m. (EST). Interested parties may participate in the conference call by dialing 800-706-7741 (U.S.) or 617-614-3471 (International) and entering passcode 67554765, 5-10 minutes prior to the initiation of the call. A replay of the conference call will be available from 1:00 p.m. (EST) on February 1, through February 8, 2006 by dialing 888-286-8010 (U.S.) or 617-801-6888 (International) and entering passcode 78654043. A webcast of the call will also be available at the GeoPharma corporate website: http://www.onlineihp.com.
GeoPharma, Inc. is a rapidly growing pharmaceutical company specializing in the manufacturing and distribution of over-the-counter, nutritional, generic drug and functional food products. The company's growth strategy is to capitalize on its manufacturing expertise to develop high margin generic or novel drugs for niche markets with high barriers to entry. GeoPharma's competitive advantage lies in its ability to circumvent or overcome the challenges in these markets. For more about GeoPharma, Inc., go to our websites at http://www.onlineihp.com and http://www.carbslim.com.
This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including those regarding the company and its subsidiaries' expectations, intentions, strategies and beliefs pertaining to future performance. All statements contained herein are based upon information available to the company's management as of the date hereof, and actual results may vary based upon future events, both within and without management's control. Important factors that could cause such differences are described in the company's periodic filings with the Securities and Exchange Commission.
GeoPharma, Inc.CONTACT: Carol Dore-Falcone, VP and CFO of GeoPharma, Inc.,+1-727-544-8866, ext. 244, cdf@onlineihp.com; or Investor and MediaRelations: Rachel Levine of The Global Consulting Group, +1-646-284-9439,rlevine@hfgcg.com
